Aigen Investment Management, LP Bausch Health Companies Inc. Transaction History
Aigen Investment Management, LP
- $579 Million
- Q1 2025
A detailed history of Aigen Investment Management, LP transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Aigen Investment Management, LP holds 13,121 shares of BHC stock, worth $63,768. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,121
Previous 22,316
41.2%
Holding current value
$63,768
Previous $179,000
53.07%
% of portfolio
0.01%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding BHC
# of Institutions
271Shares Held
243MCall Options Held
3.66MPut Options Held
11.3M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$169 Million3.02% of portfolio
-
Goldentree Asset Management LP New York, NY30.3MShares$147 Million17.26% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$128 Million9.81% of portfolio
-
Nomura Holdings Inc Tokyo, M023.4MShares$114 Million0.32% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$63.2 Million0.19% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $1.76B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...